Bloomberg
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
2 hours ago
KFGO
US FDA panel to vote on data, risk profile of Lilly Alzheimer’s drug
Seeking Alpha
Biogen stock favored at RBC as Lilly awaits Alzheimer’s drug
23 hours ago
Investing.com
RBC maintains Biogen Outperform stock rating, awaits Leqembi sales acceleration By Investing.com
1 day ago
Medscape
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
2 days ago
BioPharma Dive via Yahoo Finance
Eli Lilly adds ALS drug prospect with QurAlis deal
3 days ago
Eli Lilly Japan's Business Outlook
13 hours ago
Zacks via Yahoo Finance
The Zacks Analyst Blog Highlights Eli Lilly, T-Mobile US, BHP, American International and Exelon
Investor's Business Daily
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
5 days ago
The Motley Fool
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030 | The Motley Fool
4 days ago